Dr Blogs

Get up-to-date on CKD at AGM Conference

NICE has recently updated its clinical guideline on chronic kidney disease (CKD) to include new recommendations on the diagnosis and classification of the condition, and on its relationship with acute kidney injury.

Dr Paul Stevens, consultant nephrologist and medical director at East Kent Hospitals University NHS foundation Trust and a clinical advisor to NICE, will giving a talk at Acute & General Medicine Conference 2014 on the new guideline and other new developments in CKD.

Early diagnosis of CKD is important as it can help lower the risk of morbidity, mortality and associated healthcare costs.

The updated guideline proposes a new system for classification of CKD, which takes into consideration recently published international guidance by Kidney Disease: Improving Global Outcomes on the evaluation and management of chronic kidney disease.

NICE now recommends that CKD should be classified using a combination of glomerular filtration rate (GFR) and albumin: creatinine ratios (ACR) categories.

Dr Stevens says: “The updated classification is trying to get people to think about kidney disease in terms of an underlying diagnosis, kidney function and also markers of kidney damage. It is essentially trying to get people to consider the person in front of them with kidney disease from a prognostic point of view as well as from a diagnostic point of view.”

His talk will also cover some other recent changes in the diagnostic tests that can be used to both detect and monitor kidney disease more accurately and prevent over diagnosis.

He will also address some of the key contentious areas in the management of chronic kidney disease such as blood pressure control, whether or not acidosis should be corrected, when renal angiotensin antagonists should be used and when it is acceptable to use a standard blood pressure control agent, and the use of uric acid lowering agents and lipid lowering agents because there have been some recent changes in those areas as result of new trials.

“Things have moved on in chronic kidney disease recently.  Some people argue that for a long time we haven’t had the right sort of evidence in the management of chronic kidney disease. In terms of randomised controlled trial data if you put us next to cardiology we are an also-ran.  However we are getting better but the evidence base is still largely an observational evidence base and therein lies the problem with all observational studies which is that they don’t prove cause and effect,” says Dr Stevens.

This talk will be aimed at general physicians and doctors working in emergency departments, cardiology and diabetes.

Bookmark and Share

Post a Comment

Enter this security code

Submit Comment for Moderation